U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H17FO3S
Molecular Weight 356.411
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SULINDAC

SMILES

C[S+]([O-])C1=CC=C(\C=C2\C(C)=C(CC(O)=O)C3=C2C=CC(F)=C3)C=C1

InChI

InChIKey=MLKXDPUZXIRXEP-MFOYZWKCSA-N
InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
SULINDAC
EP   INCI   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   INCI   USAN  
Official Name English
SULINDAC [ORANGE BOOK]
Common Name English
ARTRIBID
Brand Name English
CLINORIL
Brand Name English
sulindac [INN]
Common Name English
SULINDAC [JAN]
Common Name English
SULINDAC [USAN]
Common Name English
1H-INDENE-3-ACETIC ACID, 5-FLUORO-2-METHYL-1-((4-(METHYLSULFINYL)PHENYL)METHYLENE)-, (1Z)-
Common Name English
ARTHROCINE
Brand Name English
SULINDAC [USP-RS]
Common Name English
SULINDAC [INCI]
Common Name English
NSC-757344
Code English
Sulindac [WHO-DD]
Common Name English
SULINDAC [MART.]
Common Name English
1H-INDENE-3-ACETIC ACID, 5-FLUORO-2-METHYL-1-((4-(METHYLSULFINYL)PHENYL)METHYLENE)-, (Z)-
Common Name English
SULINDAC [USP MONOGRAPH]
Common Name English
SULINDAC [EP MONOGRAPH]
Common Name English
SULINDAC [MI]
Common Name English
CIS-5-FLUORO-2-METHYL-1-((P-METHYLSULFINYL)BENZYLIDENE)INDENE-3-ACETIC ACID
Common Name English
MK-231
Code English
SULINDAC [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1323
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
WHO-ATC M01AB02
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
NDF-RT N0000175722
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
FDA ORPHAN DRUG 619917
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
LIVERTOX NBK548315
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
FDA ORPHAN DRUG 387012
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
FDA ORPHAN DRUG 818421
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
WHO-VATC QM01AB02
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
NDF-RT N0000175721
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
NDF-RT N0000000160
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
EU-Orphan Drug EU/3/12/1086
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
FDA ORPHAN DRUG 752620
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
Code System Code Type Description
CHEBI
9352
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
NSC
757344
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
FDA UNII
184SNS8VUH
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
EVMPD
SUB10744MIG
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
EPA CompTox
DTXSID4023624
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
WIKIPEDIA
SULINDAC
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
IUPHAR
5425
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
PUBCHEM
1548887
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
SMS_ID
100000092515
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
INN
3791
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
DRUG CENTRAL
2534
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
CAS
38194-50-2
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
MERCK INDEX
m10382
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C850
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
LACTMED
Sulindac
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
DAILYMED
184SNS8VUH
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
RXCUI
10237
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY RxNorm
ChEMBL
CHEMBL15770
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
DRUG BANK
DB00605
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
RS_ITEM_NUM
1642008
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
ECHA (EC/EINECS)
253-819-2
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
MESH
D013467
Created by admin on Fri Dec 15 19:14:03 UTC 2023 , Edited by admin on Fri Dec 15 19:14:03 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of SULINDAC
METABOLITE (PARENT)
Structure of SULINDAC-GLUCURONIDE
METABOLITE (PARENT)
Structure of EXISULIND
METABOLITE ACTIVE (PRODRUG)
Structure of SULINDAC SULFIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966